Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease
- PMID: 25476402
- PMCID: PMC4318759
- DOI: 10.1002/mds.26068
Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease
Abstract
Patients with Parkinson's disease (PD) may experience impulse control disorders (ICDs) when on dopamine agonist therapy for their motor symptoms. In the last few years, a rapid growth of interest for the recognition of these aberrant behaviors and their neurobiological correlates has occurred. Recent advances in neuroimaging are helping to identify the neuroanatomical networks responsible for these ICDs, and together with psychopharmacological assessments are providing new insights into the brain status of impulsive behavior. The genetic associations that may be unique to ICDs in PD are also being identified. Complementing human studies, electrophysiological and biochemical studies in animal models are providing insights into neuropathological mechanisms associated with these disorders. New animal models of ICDs in PD patients are being implemented that should provide critical means to identify efficacious therapies for PD-related motor deficits while avoiding ICD side effects. Here, we provide an overview of these recent advances, with a particular emphasis on the neurobiological correlates reported in animal models and patients along with their genetic underpinnings.
Keywords: 6-OHDA; PET; basal ganglia; dopamine agonists; fMRI; imaging; l-dopa; pramipexole; prefrontal cortex.
© 2014 International Parkinson and Movement Disorder Society.
Conflict of interest statement
T. Celeste Napier, Ph.D. Dr. Napier has no financial conflict of interest with respect to the content of this manuscript. Dr. Napier has received research support from the National Institutes of Health, the Michael J. Fox Foundation and the National Center for Responsible Gaming. Dr. Napier has received compensation for the following: consulting for a not-for-profit health education center and for law offices on issues related to addictions and impulse control disorders; speaking on addictions at community town hall meetings, public high schools, community-based not-for-profits, and professional meetings of drug courts; providing grant reviews for the National Institutes of Health and other agencies; and academic lectures and grand rounds. Dr. Napier is a member of the Illinois Alliance on Problem Gambling, and she provides expert advice to Cures Within Research Foundation, LLC.
Jean-Christophe Corvol M.D., Ph.D. has no financial conflict of interest with respect to the content of this manuscript. Dr. Corvol has received research support from the French Ministry of Health, INSERM, the French Parkinson’s disease association, and the Michael J. Fox Foundation. Dr. Corvol has received honoraria for his participation to clinical trials and travel grants for scientific meetings from Novartis, UCB, Biogen, Sanofi-Aventis.
Anthony A. Grace, Ph.D. Dr. Grace has no financial conflict of interest with respect to the content of this manuscript. Dr. Grace has received research support from the National Institutes of Health, Lundbeck, and Lilly. Dr. Grace has received compensation for consulting/honoraria from Johnson & Johnson, Lundbeck, Pfizer, GSK, Puretech Ventures, Merck, Takeda, Dainippon Sumitomo, Otsuka, Lilly, Roche, Asubio, Abbott
Jamie D. Roitman PhD. Dr. Roitman has no financial conflict of interest with respect to the content of this manuscript. Dr. Roitman has received research support from the National Institutes of Health and the Brain Research Foundation.
James B. Rowe B.M., Ph.D., FRCP. Dr. Rowe has no financial conflict of interest with respect to this manuscript. Dr Rowe has received research support from the Wellcome Trust, the Medical Research Council, the National Institute for Health Research, the James S McDonnell Foundation, the Newton Trust and Evelyn Trust.
Valerie Voon M.D., Ph.D., FRCPC. Dr. Voon has no financial conflict of interest with respect to the content of this manuscript. Dr. Voon has received support from the Wellcome Trust.
Antonio P. Strafella M.D., Ph.D., FRCPC. Dr. Strafella has no financial conflict of interest with respect to the content of this manuscript. Dr. Strafella has received research support from Canadian Institute of Health Research, Parkinson Society Canada, Parkinson Disease Foundation, National Parkinson Society, Ontario Problem Gambling Research Centre.
Figures
References
-
- Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589–595. - PubMed
-
- Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, et al. Impulse control disorders in Parkinson disease: a multicenter case--control study. Ann Neurol. 2011;69:986–996. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- NS074014/NS/NINDS NIH HHS/United States
- MC_U105597119/MRC_/Medical Research Council/United Kingdom
- F31 DA033121/DA/NIDA NIH HHS/United States
- DA036328/DA/NIDA NIH HHS/United States
- R21 DA027127/DA/NIDA NIH HHS/United States
- 088324/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- R21 DA036328/DA/NIDA NIH HHS/United States
- P01 NS019608/NS/NINDS NIH HHS/United States
- DA0331231/DA/NIDA NIH HHS/United States
- NS19608/NS/NINDS NIH HHS/United States
- G0001354/MRC_/Medical Research Council/United Kingdom
- MH57440/MH/NIMH NIH HHS/United States
- MC_US_A060_0016/MRC_/Medical Research Council/United Kingdom
- R21 NS074014/NS/NINDS NIH HHS/United States
- DA027127/DA/NIDA NIH HHS/United States
- R37 MH057440/MH/NIMH NIH HHS/United States
- R01 MH057440/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
